Loading…

Grant Application Form

Complete all steps to submit your application

Pre-filled from selected grant
PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · United States · $12.21M USD

Grant Information

Provide details about the grant you are applying for


$
Applicant Information

Tell us about yourself and your organization


$
Proposal & Supporting Documents

Provide additional details and upload your proposal document


Accepted formats: PDF, DOC, DOCX. Max size: 10MB